Bendazac

Bendazac
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Topical
ATC code M02AA11 (WHO) S01BC07 (WHO)
Identifiers
CAS Number 20187-55-7 YesY
PubChem (CID) 2313
ChemSpider 2223 YesY
UNII G4AG71204O YesY
KEGG D01594 YesY
ChEBI CHEBI:31257 N
ChEMBL CHEMBL1089221 YesY
Chemical and physical data
Formula C16H14N2O3
Molar mass 282.294 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain.

Synthesis

Principal action is inhibition of protein denaturation.

Bendazac synthesis: BE 699226 ; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).

Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).

See also

References



    This article is issued from Wikipedia - version of the 10/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.